SECOND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED LYMPHOMA AFTER A PRIOR AUTOLOGOUS TRANSPLANT

We determined treatment-related mortality (TRM), progression free survival (PFS), and overall survival (OS) after a second autologous HCT (HCT2) for patients with lymphoma relapse after a prior HCT (HCT1). Outcomes for patients with either Hodgkin lymphoma (HL, n=21) or non-Hodgkin lymphoma (NHL, n=...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Smith, Sonali M., van Besien, Koen, Carreras, Jeanette, Bashey, Asad, Cairo, Mitchell S., Freytes, Cesar O., Gale, Robert Peter, Hale, Gregory A., Hayes-Lattin, Brandon, Holmberg, Leona A., Keating, Armand, Maziarz, Richard T., McCarthy, Philip L., Navarro, Willis H., Pavlovsky, Santiago, Schouten, Harry C., Seftel, Matthew, Wiernik, Peter H., Vose, Julie M., Lazarus, Hillard M., Hari, Parameswaran
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353768/
https://ncbi.nlm.nih.gov/pubmed/18640574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.05.021
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi